Intuitive Surgical Inc ISRG

Morningstar Rating
$353.24 +3.08 (0.88%)
View Full Chart

Company Report

Intuitive's Growth Remains Strong but Market Concerned Over Entry of Competitors

Intuitive continues to benefit from the global adoption of robotic surgery, even in the procedures we didn't view as likely to convert. Our long-term positive view about the company's competitive position is unchanged even as new competitors (Medtronic and Johnson & Johnson) have finally arrived on the scene, and with the latest release of the next-generation platform, Intuitive should maintain its dominance.

Price vs Fair Value

ISRG is trading at a LOCK|sXmf?&p premium.
Price
$353.24
Fair Value
VFb
Uncertainty
LOCK|?!z
1-Star Price
LOCK|N.^
5-Star Price
LOCK|$.#%
Economic Moat
LOCK|nDj
Capital Allocation
LOCK|$&ncF&LD

Bulls Say, Bears Say

Bulls

Uptake of Intuitive's next-generation platform has been strong, giving significant momentum to system placements in the next few years.

Bears

We may be seeing the emergence of some competition, particularly for lower-cost procedures. Competition, in the form of refurbished tools, is also going after instrumentation.

News

Trading Information

Previous Close Price
$350.16
Day Range
$349.86357.99
52-Week Range
$328.57603.88
Bid/Ask
$352.25 / $353.50
Shares Outstanding
353.28M
Market Cap
$124.79B
Volume/Avg
2M / 3M

Key Statistics

Price/Earnings (Normalized)
34.53
Price/Sales
11.52
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
Total Yield
2.85%

Company Profile

Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 11,000 da Vinci systems in hospitals worldwide, with more than 6,600 installations in the US and a growing number in emerging markets.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Large Core
Total Number of Employees
17,021

Competitors

Valuation

Metric
ISRG
SYK
JNJ
Price/Earnings (Normalized)
34.5319.7424.59
Price/Book Value
6.884.407.57
Price/Sales
11.524.126.65
Price/Cash Flow
24.7318.8522.79
Price/Earnings
ISRG
SYK
JNJ

Financial Strength

Metric
ISRG
SYK
JNJ
Quick Ratio
3.641.080.73
Current Ratio
4.962.161.09
Interest Coverage
25.00
Quick Ratio
ISRG
SYK
JNJ

Profitability

Metric
ISRG
SYK
JNJ
Return on Assets (Normalized)
18.24%11.44%13.42%
Return on Equity (Normalized)
20.87%23.97%32.69%
Return on Invested Capital (Normalized)
19.08%14.10%20.33%
Return on Assets
ISRG
SYK
JNJ

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Becton Dickinson & Co
BDX
LOCK|p>YLOCK|$rlv<$49B
Alcon Inc
ALC
LOCK|&CM&byKLOCK|$^Hz$$33B
ResMed Inc
RMD
LOCK|VmR!mf@#LOCK|XxYMC$32B
Medline Inc Ordinary Shares - Class A
MDLN
LOCK|v@H%W!DLOCK|&??x$30B
West Pharmaceutical Services Inc
WST
LOCK|KmSJmJ$NLOCK|H#^$24B
Solventum Corp
SOLV
LOCK|QYdYtsfLOCK|mSl$15B
Baxter International Inc
BAX
LOCK|nsLOCK|&jWb$13B
The Cooper Companies Inc
COO
LOCK|rk#bG#LOCK|rG&$$12B
Align Technology Inc
ALGN
LOCK|@Fsxp!!LOCK|j>Z&$11B

Sponsor Center